Findings show that KANSL1 duplication is a common CNV, seen in approximately 12% of a large group of Chilean individuals, indicative that by itself it is frequent and benign, but that in combination with 22q11.2 deletion, it increases the risk of CHD. This evidence concerns the gene KANSL1 and coronary artery disorder.